<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PRF</journal-id>
<journal-id journal-id-type="hwp">spprf</journal-id>
<journal-id journal-id-type="nlm-ta">Perfusion</journal-id>
<journal-title>Perfusion</journal-title>
<issn pub-type="ppub">0267-6591</issn>
<issn pub-type="epub">1477-111X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0267659112450182</article-id>
<article-id pub-id-type="publisher-id">10.1177_0267659112450182</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The effects of zero-balance ultrafiltration on postoperative recovery after cardiopulmonary bypass: a meta-analysis of randomized controlled trials</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zhu</surname><given-names>X</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112450182">1</xref>
<xref ref-type="fn" rid="fn1-0267659112450182">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ji</surname><given-names>B</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112450182">1</xref>
<xref ref-type="fn" rid="fn1-0267659112450182">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>G</given-names></name>
<xref ref-type="aff" rid="aff2-0267659112450182">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>J</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112450182">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Long</surname><given-names>C</given-names></name>
<xref ref-type="aff" rid="aff1-0267659112450182">1</xref>
<xref ref-type="fn" rid="fn1-0267659112450182">*</xref>
</contrib>
</contrib-group>
<aff id="aff1-0267659112450182"><label>1</label>Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China</aff>
<aff id="aff2-0267659112450182"><label>2</label>Department of Anesthesia, State Key Laboratory of Cardiovascular Disease,Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China</aff>
<author-notes>
<corresp id="corresp1-0267659112450182">Bingyang Ji Associate Professor of Cardiopulmonary Bypass Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China 167 Beilishi Road, Fuwai Dajie, Xicheng qu, Beijing 100037 People’s Republic of China Email: <email>dr.ji.cpb@gmail.com</email></corresp>
<fn fn-type="other" id="fn1-0267659112450182">
<label>*</label>
<p>These two authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>5</issue>
<fpage>386</fpage>
<lpage>392</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0267659112450182">
<title>Objective:</title>
<p>Considered as a significant ultrafiltration technology during cardiopulmonary bypass (CPB), zero-balance ultrafiltration (Z-BUF) has always received controversial support regarding its effectiveness in reducing inflammatory mediators in plasma. Therefore, we conducted a meta-analysis to evaluate the clinical effect of Z-BUF through screening all relevant published randomized controlled trials (RCTs).</p>
</sec>
<sec id="section2-0267659112450182">
<title>Methods:</title>
<p>A comprehensive search was conducted to screen all RCTs of Z-BUF. Three trained investigators searched databases, including PubMed, Embase, the Cochrane Library, Google scholar, and Chinese literature databases (CNKI, WanFang, WeiPu). RCTs that compared Z-BUF with non-ultrafiltration were included. We focused on clinical outcomes such as length of stay in ICU, duration of ventilation, hospital stay, total amount of chest tube drainage and mortality. Finally, a total of 7 studies containing appropriate criteria were divided into an adult group and a pediatric group. A random effects model was used to calculate weighted mean difference with 95% confidence intervals.</p>
</sec>
<sec id="section3-0267659112450182">
<title>Results:</title>
<p>In the adult group, the benefits of Z-BUF in duration of ventilation (WMD=-2.77, 95% CI = [-6.26, 0.72], I<sup>2</sup>=71%, p=0.12) and the length of ICU stay (WMD=-4.13, 95% CI = [-10.09, 1.84], I<sup>2</sup>=77%, Z=1.36, p=0.17) were not apparent, with significant heterogeneity existing in the statistical results. The rest of the clinical parameters could not be evaluated due to insufficient data. In the pediatric group, combined analysis showed Z-BUF could reduce the duration of mechanical ventilation (WMD=3.07; 95%CI= [-7.56, -3.46], I<sup>2</sup>=17%, p=0.27). The advantage of Z-BUF was not observed in other clinical outcomes.</p>
</sec>
<sec id="section4-0267659112450182">
<title>Conclusion:</title>
<p>The benefits of Z-BUF were not apparent, according to the report. Further studies involving combined ultrafiltration are expected to provide improved ultrafiltration during CPB.</p>
</sec>
</abstract>
<kwd-group>
<kwd>cardiopulmonary bypass</kwd>
<kwd>zero-balance ultrafiltration</kwd>
<kwd>cardiac surgery</kwd>
<kwd>meta-analysis</kwd>
<kwd>clinical outcomes</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section5-0267659112450182" sec-type="intro">
<title>Introduction</title>
<p>Since its inception, cardiopulmonary bypass (CPB) has played an indispensable role in cardiac surgery. However, long-term CPB can arouse a series of adverse effects, producing the systemic inflammatory response syndrome (SIRS), ischemic reperfusion trauma, postoperative bleeding, low cardiac output and other related complications. It has been well-documented that SIRS may significantly contribute to postoperative mortality and morbidity. Complement and cytokines are activated when blood is exposed to a foreign surface. All adverse inflammatory mediators can further cause platelet and neutrophil aggregation, capillary leakage and increased systemic vascular resistance.<sup><xref ref-type="bibr" rid="bibr1-0267659112450182">1</xref></sup></p>
<p>Journois and colleagues first introduced the concept of zero-balance ultrafiltration (Z-BUF). Z-BUF could filter excess fluid, which is replaced with an equal volume of other types of colloid or crystalloid solution. According to their opinion, Z-BUF could reduce serum inflammatory mediator concentrations and modify clinical manifestation.<sup><xref ref-type="bibr" rid="bibr2-0267659112450182">2</xref></sup> For over ten years, various laboratory and clinical studies associated with Z-BUF have been designed to determine whether Z-BUF alleviates patient postoperative inflammation or improves patient recovery in the ICU. Even so, the available study outcomes are insufficient to reach a consensus. In 2011, Z-BUF was designated as IIb (a) type of evidence by The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. The level of the evidence indicates that the usefulness of Z-BUF is less well established and needs multiple randomized trials or meta-analyses.<sup><xref ref-type="bibr" rid="bibr3-0267659112450182">3</xref></sup></p>
<p>To provide convincing evidence for the clinical application of Z-BUF, we decided to conduct a systematic review and meta-analysis, using a statistical tool to pool all the data collected from existing randomized trials to appraise the clinical effects of Z-BUF in cardiac surgery.</p>
</sec>
<sec id="section6-0267659112450182" sec-type="methods">
<title>Methods</title>
<p>To complete convincing analysis results, our group formulated a detailed plan, including a search strategy, a study selection and quality assessment, statistical analysis and synthesis data extraction. The basis for the plan is from preferred reporting items for systematic reviews and meta-analysis (PRISMA).<sup><xref ref-type="bibr" rid="bibr4-0267659112450182">4</xref></sup></p>
<sec id="section7-0267659112450182">
<title>Search Strategy</title>
<p>Randomized controlled trials were comprehensively searched in PubMed, Embase, the Cochrane Library, Google scholar and Chinese literature databases (CNKI, WanFang, WeiPu). Search words that we used during the search procedure consisted of “cardiopulmonary bypass”, “extracorporeal circulation”, “cardiac surgery”, “ultrafiltration”, “zero balance ultrafiltration” and “balance ultrafiltration”. The Reference lists of included articles were also searched. No language and time restrictions were performed in the process of searching.</p>
</sec>
<sec id="section8-0267659112450182">
<title>Study Selection and Quality Assessment</title>
<p>In our opinion, Z-BUF was defined as an ultrafiltration procedure that could remove fluid while adding an equal volume of balanced salt solution into the venous reservoir. The commencement time of Z-BUF had no definite standard. Human RCTs were included without any age limitation. If Z-BUF was combined with other ultrafiltration procedures, such as modified ultrafiltration (MUF) or conventional ultrafiltration (CUF), the study was excluded. Studies without the application of ultrafiltration in the control group were included. The outcomes of interest were relevant clinical indices, including the length of ICU stay, duration of ventilation, length of hospital stay, total amount of chest tube drainage and mortality. The JADAD score was used to assess the quality of the included studies.<sup><xref ref-type="bibr" rid="bibr5-0267659112450182">5</xref></sup></p>
</sec>
<sec id="section9-0267659112450182">
<title>Statistical Analysis and Synthesis</title>
<p>All studies included were divided into an adult group and a pediatric group. The effect size of continuous variables was expressed as relative risk (RR) while the other was expressed as standard weighted mean difference and 95% confidence interval (CI). The random effects model was chosen to conduct combined analysis. Statistical heterogeneity was evaluated by I<sup>2</sup> and Q test. The conclusion of this review should be interpreted carefully when the value of I<sup>2</sup>&gt;50% or P&lt;0.5. RevMan5.1 (version 5.1.Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011) was used to analyze all the statistical data.</p>
</sec>
<sec id="section10-0267659112450182">
<title>Data Extraction</title>
<p>To ensure the accuracy and integrity of the data, three trained investigators were allowed to screen all RCTs that conformed to our inclusion standards. The basic characteristics of patients (<xref ref-type="table" rid="table1-0267659112450182">Table 1</xref>) and parameters of the ultrafiltration process (<xref ref-type="table" rid="table2-0267659112450182">Table 2</xref>) were extracted and recorded in the form of tables, with differing opinions finally reaching a consensus by discussion.</p>
<table-wrap id="table1-0267659112450182" position="float">
<label>Table 1.</label>
<caption>
<p>Basic characteristic of included studies</p>
</caption>
<graphic alternate-form-of="table1-0267659112450182" xlink:href="10.1177_0267659112450182-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="left">Year</th>
<th align="left">Number</th>
<th align="left">Ultrafiltration</th>
<th align="left">Age(y)</th>
<th align="left">Jadad Score</th>
</tr>
</thead>
<tbody>
<tr>
<td>De Baar M<sup><xref ref-type="bibr" rid="bibr6-0267659112450182">6</xref></sup></td>
<td>2003</td>
<td>60</td>
<td>No ultrafiltration</td>
<td>66±9</td>
<td>2</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Z-BUF</td>
<td>67±8</td>
<td/>
</tr>
<tr>
<td>Tallman RD<sup><xref ref-type="bibr" rid="bibr7-0267659112450182">7</xref></sup></td>
<td>2002</td>
<td>30</td>
<td>No ultrafiltration</td>
<td>62.8±7.29</td>
<td>3</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Z-BUF</td>
<td>62.67±9.48</td>
<td/>
</tr>
<tr>
<td>Li Gang<sup><xref ref-type="bibr" rid="bibr8-0267659112450182">8</xref></sup></td>
<td>2009</td>
<td>45</td>
<td>No ultrafiltration</td>
<td>61.7±5.4</td>
<td>2</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Z-BUF</td>
<td>63±5.0</td>
<td/>
</tr>
<tr>
<td>Li Yu-mei<sup><xref ref-type="bibr" rid="bibr9-0267659112450182">9</xref></sup></td>
<td>2008</td>
<td>20</td>
<td>No ultrafiltration</td>
<td>Range(60-75)</td>
<td>2</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Z-BUF</td>
<td>Range(60-75)</td>
<td/>
</tr>
<tr>
<td>Zheng Min<sup><xref ref-type="bibr" rid="bibr10-0267659112450182">10</xref></sup></td>
<td>2006</td>
<td>40</td>
<td>No ultrafiltration</td>
<td>Range(36-69)</td>
<td>2</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Z-BUF</td>
<td>Range(19-67)</td>
<td/>
</tr>
<tr>
<td>Zhao Ju<sup><xref ref-type="bibr" rid="bibr11-0267659112450182">11</xref></sup></td>
<td>2005</td>
<td>20</td>
<td>No ultrafiltration</td>
<td>Pediatric group</td>
<td>3</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Z-BUF</td>
<td/>
<td/>
</tr>
<tr>
<td>Sun Yue-dong<sup><xref ref-type="bibr" rid="bibr12-0267659112450182">12</xref></sup></td>
<td>2006</td>
<td>20</td>
<td>No ultrafiltration</td>
<td>Pediatric group</td>
<td>2</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td>Z-BUF</td>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0267659112450182">
<p>Z-BUF, zero-balance ultrafiltration</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table2-0267659112450182" position="float">
<label>Table 2.</label>
<caption>
<p>Parameters of Z-BUF</p>
</caption>
<graphic alternate-form-of="table2-0267659112450182" xlink:href="10.1177_0267659112450182-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Study</th>
<th align="left">Super filter types</th>
<th align="left">Start time of Z-BUF</th>
<th align="left">Ultrafiltration volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>De Baar M<sup><xref ref-type="bibr" rid="bibr6-0267659112450182">6</xref></sup></td>
<td>Minntech</td>
<td>After CPB</td>
<td>40 mL/min/m<sup>2</sup></td>
</tr>
<tr>
<td>Tallman RD<sup><xref ref-type="bibr" rid="bibr7-0267659112450182">7</xref></sup></td>
<td>Minntech</td>
<td>15min after CPB</td>
<td>3L/m<sup>2</sup></td>
</tr>
<tr>
<td>Li Gang<sup><xref ref-type="bibr" rid="bibr8-0267659112450182">8</xref></sup></td>
<td>Terumo</td>
<td>After CPB</td>
<td>300-400ml/min</td>
</tr>
<tr>
<td>Li Yu-mei<sup><xref ref-type="bibr" rid="bibr9-0267659112450182">9</xref></sup></td>
<td>Terumo</td>
<td>After aortic cross-clamp</td>
<td>50ml/kg</td>
</tr>
<tr>
<td>Zheng Min<sup><xref ref-type="bibr" rid="bibr10-0267659112450182">10</xref></sup></td>
<td>Terumo</td>
<td>After aortic cross-clamp</td>
<td>60ml/kg</td>
</tr>
<tr>
<td>Zhao Ju<sup><xref ref-type="bibr" rid="bibr11-0267659112450182">11</xref></sup></td>
<td>Gambro</td>
<td>No report</td>
<td>300ml</td>
</tr>
<tr>
<td>Sun Yue-dong<sup><xref ref-type="bibr" rid="bibr12-0267659112450182">12</xref></sup></td>
<td>German</td>
<td>After CPB</td>
<td>10 mL/min/kg</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0267659112450182">
<p>CPB, cardiopulmonary bypass.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section11-0267659112450182" sec-type="results">
<title>Results</title>
<p>Finally, a total of seven RCTs<sup><xref ref-type="bibr" rid="bibr6-0267659112450182">6</xref><xref ref-type="bibr" rid="bibr7-0267659112450182"/><xref ref-type="bibr" rid="bibr8-0267659112450182"/><xref ref-type="bibr" rid="bibr9-0267659112450182"/><xref ref-type="bibr" rid="bibr10-0267659112450182"/><xref ref-type="bibr" rid="bibr11-0267659112450182"/>-<xref ref-type="bibr" rid="bibr12-0267659112450182">12</xref></sup> conformed to our criteria, including five adult studies and two pediatric studies (<xref ref-type="fig" rid="fig1-0267659112450182">Figure 1</xref>). In the process of screening, 20 non-RCTs and 20 RCTs without eligible clinical outcomes were excluded. In addition, eight trials were excluded after reviewing full texts. Of these eight trials, two trials<sup><xref ref-type="bibr" rid="bibr13-0267659112450182">13</xref>,<xref ref-type="bibr" rid="bibr14-0267659112450182">14</xref></sup> used sub-zero-balance ultrafiltration that combined CUF and Z-BUF, one trial<sup><xref ref-type="bibr" rid="bibr15-0267659112450182">15</xref></sup> used a steroid during cardiopulmonary bypass, while six other trials applied combined ultrafiltration. Therefore, 195 adult patients and 40 pediatric patients were included in this meta-analysis. We divided all these trials into two groups, an adult group and a pediatric group, for the purpose of reducing heterogeneity. A random number table was applied in the first trial, while the blind method was used in the second trial. The mean value of the JADAD score was 2.3 (range 2-3). Because of significant heterogeneity, it was essential to analyze adults and children separately.</p>
<fig id="fig1-0267659112450182" position="float">
<label>Figure 1.</label>
<caption>
<p>A flowchart of screening studies. RCT, randomized controlled trial.</p>
</caption>
<graphic xlink:href="10.1177_0267659112450182-fig1.tif"/>
</fig>
<sec id="section12-0267659112450182">
<title>Adult Group</title>
</sec>
<sec id="section13-0267659112450182">
<title>Duration of Ventilation</title>
<p>The duration of ventilation was reported in 5 trials,<sup><xref ref-type="bibr" rid="bibr6-0267659112450182">6</xref><xref ref-type="bibr" rid="bibr7-0267659112450182"/><xref ref-type="bibr" rid="bibr8-0267659112450182"/><xref ref-type="bibr" rid="bibr9-0267659112450182"/>-<xref ref-type="bibr" rid="bibr10-0267659112450182">10</xref></sup> including 180 patients. An article with inexplicable data (control group: 7±23, Z-BUF group: 5±17) was excluded after sending an e-mail to the author, who did not reply. Of four studies, three failed to reveal any significant statistical differences. Significant reduction of ventilation time was not observed after combined analysis (WMD=-2.77, 95% CI = [-6.26, 0.72], I<sup>2</sup>=71%, <italic>p</italic>=0.12). However, significant heterogeneity was present between the included studies (<xref ref-type="fig" rid="fig2-0267659112450182">Figure 2</xref>).</p>
<fig id="fig2-0267659112450182" position="float">
<label>Figure 2.</label>
<caption>
<p>Duration of ventilation in adult group (hours).</p>
</caption>
<graphic xlink:href="10.1177_0267659112450182-fig2.tif"/>
</fig>
</sec>
<sec id="section14-0267659112450182">
<title>Length of stay in ICU</title>
<p>Only three studies<sup><xref ref-type="bibr" rid="bibr7-0267659112450182">7</xref><xref ref-type="bibr" rid="bibr8-0267659112450182"/>-<xref ref-type="bibr" rid="bibr9-0267659112450182">9</xref></sup> reported data about the length of ICU stay, a total of 80 patients. The unit of day was used in one article,<sup><xref ref-type="bibr" rid="bibr7-0267659112450182">7</xref></sup> so we converted it to hours, one day equal to 24h. No significant statistical differences were found between the two groups (WMD=-4.13: 95% CI= [-10.09, 1.84], I<sup>2</sup>=77%, Z=1.36: <italic>p</italic>=0.17). Significant heterogeneity was observed in the meta-analysis results (<xref ref-type="fig" rid="fig3-0267659112450182">Figure 3</xref>).</p>
<fig id="fig3-0267659112450182" position="float">
<label>Figure 3.</label>
<caption>
<p>The length of ICU stay in the adult group (hours).</p>
</caption>
<graphic xlink:href="10.1177_0267659112450182-fig3.tif"/>
</fig>
</sec>
<sec id="section15-0267659112450182">
<title>Hospital stay, mortality and chest tube drainage</title>
<p>Data regarding hospital stay was found in only one study.<sup><xref ref-type="bibr" rid="bibr7-0267659112450182">7</xref></sup> No statistical differences (p=0.407) were reported in the study published by Tallman and other colleagues. De Baar<sup><xref ref-type="bibr" rid="bibr6-0267659112450182">6</xref></sup> reported one death due to postoperative myocardial infarction. No other deaths were reported in the rest of included articles. Due to insufficient data, we did not estimate the relationship between mortality and the application of Z-BUF during CPB. No studies reported the clinical outcome of chest tube drainage.</p>
</sec>
<sec id="section16-0267659112450182">
<title>Pediatric Group</title>
<p>Only two RCTs<sup><xref ref-type="bibr" rid="bibr11-0267659112450182">11</xref>, <xref ref-type="bibr" rid="bibr12-0267659112450182">12</xref></sup> were in this group. Data of duration of ventilation was found in both studies. Combined analysis showed improvement of respiratory function and reduction of mechanical ventilation time (WMD=3.07, 95%CI=[-7.56,-3.46], I<sup>2</sup>=17%, p=0.27). Shortened length of ICU stay was reported in one article<sup><xref ref-type="bibr" rid="bibr12-0267659112450182">12</xref></sup> (p&lt;0.05) (<xref ref-type="fig" rid="fig4-0267659112450182">Figure 4</xref>). Other relevant data, such as mortality, chest tube drainage and hospital stay were not fully reported.</p>
<fig id="fig4-0267659112450182" position="float">
<label>Figure 4.</label>
<caption>
<p>Duration of ventilation time in the pediactric group (hours).</p>
</caption>
<graphic xlink:href="10.1177_0267659112450182-fig4.tif"/>
</fig>
</sec>
</sec>
<sec id="section17-0267659112450182" sec-type="discussion">
<title>Discussion</title>
<p>Ultrafiltration technology is considered an effective strategy to reduce the degree of systemic edema and remove various kinds of inflammation. At present, there are three kinds of ultrafiltration: conventional, modified and zero-balance ultrafiltration. Clinical benefits of CUF and MUF have reached agreement.<sup><xref ref-type="bibr" rid="bibr16-0267659112450182">16</xref>,<xref ref-type="bibr" rid="bibr17-0267659112450182">17</xref></sup> Since the first presentation of Z-BUF,<sup><xref ref-type="bibr" rid="bibr2-0267659112450182">2</xref></sup> Journois and colleagues showed that the postoperative plasma concentrations of mediators of inflammation, TNF-α, IL-1, IL-6, IL-8 and others decreased at different time points after cardiac surgery. In 2002, a randomized controlled trial also showed evidence that Z-BUF could filter large amounts of inflammation mediators.<sup><xref ref-type="bibr" rid="bibr7-0267659112450182">7</xref></sup> However, the article proposed another view that Z-BUF could probably strengthen the inflammatory reaction associated with cardiopulmonary bypass by removing IL-10 and other anti-inflammatory mediators. Another proof indicated that Z-BUF could remove inflammatory mediators more effectively than corticosteroid in a pediatric trial.<sup><xref ref-type="bibr" rid="bibr15-0267659112450182">15</xref></sup> All the research described above provided a theoretical basis for the clinical application of Z-BUF.</p>
<p>In this meta-analysis, efforts were made to find more reliable evidence through combined analysis. In the pooled results of the adult group, we failed to find significant statistical differences in any of the postoperative clinical parameters. On the other hand, significant heterogeneity was found among the included trials. The reasons are listed as follows: (1) differences in Z-BUF application styles among the included trials were varied, including the quantity of balanced ultrafiltration fluid, start time, duration and filter brand of Z-BUF; (2) characteristics of the included studies, consisting of age, sex, disease, etc., differed from one another. In terms of hospital stay, mortality and chest tube drainage, reliable evaluation was not obtainable for these clinical parameters due to insufficient data. In the pediatric group, limited to two trials, the Z-BUF group when compared to the control group showed a reduction in mechanical ventilation duration and ICU stay, but too little data limited the credibility of the results.</p>
<p>Hemodilution and systemic inflammation, as two vital causes of patient postoperative complications, have always been the focus of the research. Without the removal of fluid, the value of Z-BUF would be dramatically reduced. Concerning this issue, some scholars suggested using combined ultrafiltration. Tao Zhang, et al.<sup><xref ref-type="bibr" rid="bibr13-0267659112450182">13</xref></sup> divided 94 patients into 2 groups: ultrafiltration group and non-ultrafiltration group. After aortic cross-clamping, ultrafiltration was commenced at the rate of 10-20ml/kg. At the beginning of rewarming, the ultrafiltration rate was adjusted to 50-100ml/kg while lactated Ringer’s solution was added to the venous reservoir volume chambers to ensure the required level of liquid and maintain an acceptable hematocrit (Hct&gt;25%). The final results revealed that combined ultrafiltration could reduce the amount of postoperative blood product usage and the duration of ventilation time, but no significant statistical heterogeneity was observed in other clinical parameters, such as the length of stay in the ICU, hospital stay and the duration of ventilation.<sup><xref ref-type="bibr" rid="bibr13-0267659112450182">13</xref></sup> Besides this, other studies on combined ultrafiltration also offer strong evidence for clinical application.<sup><xref ref-type="bibr" rid="bibr18-0267659112450182">18</xref><xref ref-type="bibr" rid="bibr19-0267659112450182"/>-<xref ref-type="bibr" rid="bibr20-0267659112450182">20</xref></sup> The meta-analysis did not include studies associated with combined ultrafiltration, but combined ultrafiltration may become a future developmental trend.</p>
<p>In spite of strict inclusion criteria, careful data extraction and objective analysis, several limitations were found, as follows:</p>
<list id="list1-0267659112450182" list-type="roman-upper">
<list-item><p>The number of RCTs having the necessary inclusion criteria was insufficient.</p></list-item>
<list-item><p>Publication bias and sensitivity analysis were not conducted due to an insufficient number of included studies.</p></list-item>
<list-item><p>The quality of the included articles was low, according to the JADAD score.</p></list-item>
<list-item><p>The validity of the analysis results was influenced by the application styles without any uniform standard.</p></list-item>
<list-item><p>The application of Z-BUF not combined with other ultrafiltration procedures could augment the drawback that Z-BUF could not remove extra fluid from the entire body. The clinical benefits related to the reduction of inflammation could be weakened.</p></list-item>
</list>
</sec>
<sec id="section18-0267659112450182" sec-type="conclusions">
<title>Conclusion</title>
<p>Overall, we failed to provide positive evidence with the clinical application of Z-BUF. Considering the certain fact of its ability to remove inflammation mediators, we expect further research of Z-BUF, especially combined with CUF and MUF.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of Interest Statement</label>
<p>None declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0267659112450182">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heyn</surname><given-names>J</given-names></name>
<name><surname>Beiras-Fernandez</surname><given-names>A</given-names></name>
<name><surname>Luchting</surname><given-names>B</given-names></name>
<name><surname>Briegel</surname><given-names>J</given-names></name>
<name><surname>Weis</surname><given-names>F</given-names></name>
</person-group>. <article-title>Inflammatory reactions and hydrocortisone in the setting of cardiac surgery: an overview</article-title>. <source>Cardiovasc Hematol Agents Med Chem</source> <year>2011</year>; <volume>9</volume>: <fpage>56</fpage>–<lpage>61</lpage>.</citation>
</ref>
<ref id="bibr2-0267659112450182">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Journois</surname><given-names>D</given-names></name>
<name><surname>Israel-Biet</surname><given-names>D</given-names></name>
<name><surname>Pouard</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children</article-title>. <source>Anesthesiology</source> <year>1996</year>; <volume>85</volume>: <fpage>965</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr3-0267659112450182">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferraris</surname><given-names>VA</given-names></name>
<name><surname>Brown</surname><given-names>JR</given-names></name>
<name><surname>Despotis</surname><given-names>GJ</given-names></name>
<etal/>
</person-group>. <article-title>2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines</article-title>. <source>Ann Thorac Surg</source> <year>2011</year>; <volume>91</volume>: <fpage>944</fpage>–<lpage>982</lpage>.</citation>
</ref>
<ref id="bibr4-0267659112450182">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moher</surname><given-names>D</given-names></name>
<name><surname>Liberati</surname><given-names>A</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J</given-names></name>
<name><surname>Altman</surname><given-names>DG</given-names></name>
</person-group>, <collab>for the PRISMA Group</collab>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>BMJ</source> <year>2009</year>; <volume>339</volume>: <fpage>b2535</fpage>–<lpage>b2535</lpage>.</citation>
</ref>
<ref id="bibr5-0267659112450182">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jadad</surname><given-names>AR</given-names></name>
<name><surname>Moor</surname><given-names>RA</given-names></name>
<name><surname>Carroll</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Assessing the quality of reports of randomized clinical trials: is blinding necessary?</article-title> <source>Controlled Clin Trials</source> <year>1996</year>; <volume>17</volume>: <fpage>1</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr6-0267659112450182">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Baar</surname><given-names>M</given-names></name>
<name><surname>Diephuis</surname><given-names>JC</given-names></name>
<name><surname>Moons</surname><given-names>KG</given-names></name>
<name><surname>Holtkamp</surname><given-names>J</given-names></name>
<name><surname>Hijman</surname><given-names>R</given-names></name>
<name><surname>Kalkman</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>The effect of zero-balanced ultrafiltration during cardiopulmonary bypass on S100b release and cognitive function</article-title>. <source>Perfusion</source> <year>2003</year>; <volume>18</volume>: <fpage>9</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr7-0267659112450182">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tallman</surname><given-names>RD</given-names></name>
<name><surname>Dumond</surname><given-names>M</given-names></name>
<name><surname>Brown</surname><given-names>D</given-names></name>
</person-group>. <article-title>Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass</article-title>. <source>Perfusion</source> <year>2002</year>; <volume>17</volume>: <fpage>111</fpage>–<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr8-0267659112450182">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gang</surname><given-names>Li</given-names></name>
<name><surname>Lifang</surname><given-names>Cui</given-names></name>
<name><surname>Shengfa</surname><given-names>Zheng</given-names></name>
<name><surname>Nianliang</surname><given-names>Zhang</given-names></name>
<name><surname>Wei</surname><given-names>Wei</given-names></name>
<name><surname>Huiqiang</surname><given-names>Wang</given-names></name>
</person-group>. <article-title>Effects of high-volume zero-balance ultrafiltration on reduced inflammatory response to on-pump vs off-pump CABG [Chinese]</article-title>. <source>Chin J CPB</source> <year>2009</year>; <volume>7</volume>: <fpage>142</fpage>–<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr9-0267659112450182">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yumei</surname><given-names>Li</given-names></name>
<name><surname>Shengfa</surname><given-names>Zheng</given-names></name>
<name><surname>Enqin</surname><given-names>Wang</given-names></name>
</person-group>. <article-title>Zero-balanced ultrafiltration on perioperative cardiopulmonary function in senile patients undergoing coronary artery bypass graft [Chinese]</article-title>. <source>Chin J Mult Organ Dis Elderly</source> <year>2008</year>; <volume>7</volume>: <fpage>290</fpage>–<lpage>292</lpage>.</citation>
</ref>
<ref id="bibr10-0267659112450182">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Min</surname><given-names>Zheng</given-names></name>
<name><surname>Wei</surname><given-names>Zhang</given-names></name>
<name><surname>Zheng</surname><given-names>Guo</given-names></name>
<name><surname>Xin</surname><given-names>Li</given-names></name>
<name><surname>Wei</surname><given-names>Ye</given-names></name>
</person-group>. <article-title>Effect of zero-balanced ultrafiltration on postoperative lung function in replaced cardiac valve cases [Chinese]</article-title>. <source>Chin J ECC</source> <year>2006</year>; <volume>4</volume>: <fpage>72</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr11-0267659112450182">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ju</surname><given-names>Zhao</given-names></name>
<name><surname>Cun</surname><given-names>Long</given-names></name>
<name><surname>Zheng-yi</surname><given-names>Feng</given-names></name>
<name><surname>Jiu-guang</surname><given-names>Yang</given-names></name>
<name><surname>Feng-ling</surname><given-names>Liang</given-names></name>
</person-group>. <article-title>Effects on inflammatory responses of zero-balanced ultrafiltration of stored blood priming solution in infant cardiopulmonary bypass [Chinese]</article-title>. <source>Chin J Clin Thorac Cardiovasc Surg</source> <year>2005</year>; <volume>12</volume>: <fpage>396</fpage>–<lpage>398</lpage>.</citation>
</ref>
<ref id="bibr12-0267659112450182">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yue-dong</surname><given-names>Sun</given-names></name>
</person-group>. <article-title>The study of through balance ultrafiltration to improve pulmonary function after extracorporeal circulation [Chinese]</article-title>. <source>Chinese Journal of Birth Health&amp;Heredity</source> <year>2006</year>; <volume>14</volume>: <fpage>119</fpage>–<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr13-0267659112450182">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>T</given-names></name>
<name><surname>Jiang</surname><given-names>SL</given-names></name>
<name><surname>Gao</surname><given-names>CQ</given-names></name>
<name><surname>Luo</surname><given-names>J</given-names></name>
<name><surname>Ma</surname><given-names>L</given-names></name>
<name><surname>Li</surname><given-names>JC</given-names></name>
</person-group>. <article-title>Effect of subzero-balanced ultrafiltration on lung gas exchange capacity after cardiopulmonary bypass in adult patients with heart valve disease</article-title>. <source>Heart Surg Forum</source> <year>2011</year>; <volume>14</volume>: <fpage>E22</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr14-0267659112450182">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tao</surname><given-names>Z</given-names></name>
<name><surname>Gao</surname><given-names>CQ</given-names></name>
<name><surname>Li</surname><given-names>JC</given-names></name>
<name><surname>Wang</surname><given-names>JL</given-names></name>
<name><surname>Li</surname><given-names>LB</given-names></name>
<name><surname>Xiao</surname><given-names>CS</given-names></name>
</person-group>. <article-title>Effect of subzero-balanced ultrafiltration on postoperative outcome of patients after cardiopulmonary bypass</article-title>. <source>Perfusion</source> <year>2009</year>; <volume>24</volume>: <fpage>401</fpage>–<lpage>408</lpage>.</citation>
</ref>
<ref id="bibr15-0267659112450182">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>J</given-names></name>
<name><surname>Ji</surname><given-names>B</given-names></name>
<name><surname>Long</surname><given-names>C</given-names></name>
<name><surname>Li</surname><given-names>C</given-names></name>
<name><surname>Feng</surname><given-names>Z</given-names></name>
</person-group>. <article-title>Comparative effectiveness of methylprednisolone and zero-balance ultrafiltration on inflammatory response after pediatric cardiopulmonary bypass</article-title>. <source>Artif Organs</source> <year>2007</year>; <volume>31</volume>: <fpage>571</fpage>–<lpage>575</lpage>.</citation>
</ref>
<ref id="bibr16-0267659112450182">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuratani</surname><given-names>N</given-names></name>
<name><surname>Bunsangjaroen</surname><given-names>P</given-names></name>
<name><surname>Srimueang</surname><given-names>T</given-names></name>
<name><surname>Masaki</surname><given-names>E</given-names></name>
<name><surname>Suzuki</surname><given-names>T</given-names></name>
<name><surname>Katogi</surname><given-names>T</given-names></name>
</person-group>. <article-title>Modified versus conventional ultrfiltration in pediatric cardiac surgery: a meta-analysis of randomized controlled trials comparing clinical outcome parameters</article-title>. <source>J Thorac Cardiovasc Surg</source> <year>2011</year>; <volume>142</volume>: <fpage>861</fpage>–<lpage>867</lpage>.</citation>
</ref>
<ref id="bibr17-0267659112450182">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boodhwani</surname><given-names>M</given-names></name>
<name><surname>Williams</surname><given-names>K</given-names></name>
<name><surname>Babaev</surname><given-names>A</given-names></name>
<name><surname>Gill</surname><given-names>G</given-names></name>
<name><surname>Saleem</surname><given-names>N</given-names></name>
<name><surname>Rubens</surname><given-names>FD</given-names></name>
</person-group>. <article-title>Ultrafiltration reduces blood transfusions following cardiac surgery: a meta-analysis</article-title>. <source>Eur J Cardiothorac Surg</source> <year>2006</year>; <volume>30</volume>: <fpage>892</fpage>–<lpage>897</lpage>.</citation>
</ref>
<ref id="bibr18-0267659112450182">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tassani</surname><given-names>P</given-names></name>
<name><surname>Richter</surname><given-names>JA</given-names></name>
<name><surname>Eising</surname><given-names>GP</given-names></name>
<etal/>
</person-group>. <article-title>Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting</article-title>. <source>J Cardiothorac Vasc Anesth</source> <year>1999</year>; <volume>13</volume>: <fpage>285</fpage>–<lpage>291</lpage>.</citation>
</ref>
<ref id="bibr19-0267659112450182">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qin</surname><given-names>Fang</given-names></name>
<name><surname>Tian-xiang</surname><given-names>Gu</given-names></name>
<name><surname>Rui</surname><given-names>Gao</given-names></name>
<name><surname>Li-min</surname><given-names>Wu</given-names></name>
<name><surname>Shi</surname><given-names>Cheng</given-names></name>
<name><surname>Zhi-xiang</surname><given-names>Gao</given-names></name>
</person-group>. <article-title>Effect of zero-balanced ultrafiltration on postoperative lung function in coronary artery bypass grafting patients [Chinese]</article-title>. <source>Chin J Clin Thorac Cardiovasc Surg</source> <year>2011</year>; <volume>2</volume>: <fpage>22</fpage>–<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr20-0267659112450182">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xiao-yun</surname><given-names>Yang</given-names></name>
<name><surname>Bao-yu</surname><given-names>Liu</given-names></name>
<name><surname>Kai</surname><given-names>Zhou</given-names></name>
<etal/>
</person-group>. <article-title>The effect of compound ultrafiltration on postoperative pulmonary function of patients with cardiac valve replacement [Chinese]</article-title>. <source>Chin J ECC</source> <year>2008</year>, <volume>6</volume>: <fpage>197</fpage>–<lpage>200</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>